Search Results - "NAKAMYA, Juliet"

Left Atrial Appendage Occlusion during Cardiac Surgery to Prevent Stroke by Whitlock, Richard P, Belley-Cote, Emilie P, Paparella, Domenico, Healey, Jeff S, Brady, Katheryn, Sharma, Mukul, Reents, Wilko, Budera, Petr, Baddour, Andony J, Fila, Petr, Devereaux, P.J, Bogachev-Prokophiev, Alexander, Boening, Andreas, Teoh, Kevin H.T, Tagarakis, Georgios I, Slaughter, Mark S, Royse, Alistair G, McGuinness, Shay, Alings, Marco, Punjabi, Prakash P, Mazer, C. David, Folkeringa, Richard J, Colli, Andrea, Avezum, Álvaro, Nakamya, Juliet, Balasubramanian, Kumar, Vincent, Jessica, Voisine, Pierre, Lamy, Andre, Yusuf, Salim, Connolly, Stuart J

“…In a randomized trial, 4811 patients with atrial fibrillation were assigned to undergo or not undergo left atrial appendage occlusion during cardiac surgery…”
Get full text

Complete Revascularization with Multivessel PCI for Myocardial Infarction by Mehta, Shamir R, Wood, David A, Storey, Robert F, Mehran, Roxana, Bainey, Kevin R, Nguyen, Helen, Meeks, Brandi, Di Pasquale, Giuseppe, López-Sendón, Jose, Faxon, David P, Mauri, Laura, Rao, Sunil V, Feldman, Laurent, Steg, P. Gabriel, Avezum, Álvaro, Sheth, Tej, Pinilla-Echeverri, Natalia, Moreno, Raul, Campo, Gianluca, Wrigley, Benjamin, Kedev, Sasko, Sutton, Andrew, Oliver, Richard, Rodés-Cabau, Josep, Stanković, Goran, Welsh, Robert, Lavi, Shahar, Cantor, Warren J, Wang, Jia, Nakamya, Juliet, Bangdiwala, Shrikant I, Cairns, John A

“…Patients with ST-segment elevation MI and multivessel coronary disease who had undergone successful culprit-lesion PCI were assigned to a strategy of either…”
Get full text

Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa Inhibitors by Connolly, Stuart J, Crowther, Mark, Eikelboom, John W, Gibson, C. Michael, Curnutte, John T, Lawrence, John H, Yue, Patrick, Bronson, Michele D, Lu, Genmin, Conley, Pamela B, Verhamme, Peter, Schmidt, Jeannot, Middeldorp, Saskia, Cohen, Alexander T, Beyer-Westendorf, Jan, Albaladejo, Pierre, Lopez-Sendon, Jose, Demchuk, Andrew M, Pallin, Daniel J, Concha, Mauricio, Goodman, Shelly, Leeds, Janet, Souza, Sonia, Siegal, Deborah M, Zotova, Elena, Meeks, Brandi, Ahmad, Sadia, Nakamya, Juliet, Milling, Truman J

“…In a single-group trial, 352 patients with acute major bleeding while taking a factor Xa inhibitor were treated with andexanet. Andexanet markedly reduced…”
Get full text

Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors by Connolly, Stuart J, Milling, Truman J, Eikelboom, John W, Gibson, C. Michael, Curnutte, John T, Gold, Alex, Bronson, Michele D, Lu, Genmin, Conley, Pamela B, Verhamme, Peter, Schmidt, Jeannot, Middeldorp, Saskia, Cohen, Alexander T, Beyer-Westendorf, Jan, Albaladejo, Pierre, Lopez-Sendon, Jose, Goodman, Shelly, Leeds, Janet, Wiens, Brian L, Siegal, Deborah M, Zotova, Elena, Meeks, Brandi, Nakamya, Juliet, Lim, W. Ting, Crowther, Mark

“…Andexanet alfa, a catalytically inactive decoy of factor Xa, successfully reversed the factor Xa inhibitory effects of rivaroxaban and apixaban in a small…”
Get full text

Temporal Relationship Between Subclinical Atrial Fibrillation and Embolic Events by Brambatti, Michela, Connolly, Stuart J, Gold, Michael R, Morillo, Carlos A, Capucci, Alessandro, Muto, Carmine, Lau, Chu P, Van Gelder, Isabelle C, Hohnloser, Stefan H, Carlson, Mark, Fain, Eric, Nakamya, Juliet, Mairesse, Georges H, Halytska, Marta, Deng, Wei Q, Israel, Carsten W, Healey, Jeff S

“…BACKGROUND—Among patients with implantable pacemakers and defibrillators, subclinical atrial fibrillation (SCAF) is associated with an increased risk of…”
Get full text

Occurrence of death and stroke in patients in 47 countries 1 year after presenting with atrial fibrillation: a cohort study by Healey, Jeff S, Dr, Oldgren, Jonas, MD, Ezekowitz, Michael, Prof, Zhu, Jun, MD, Pais, Prem, Prof, Wang, Jia, Msc, Commerford, Patrick, MD, Jansky, Petr, MD, Avezum, Alvaro, MD, Sigamani, Alben, MD, Demasceno, Albertino, MD, Reilly, Paul, PhD, Grinvalds, Alex, BSc, Nakamya, Juliet, PhD, Aje, Akinyemi, MD, Almahmeed, Wael, MD, Moriarty, Andrew, MD, Wallentin, Lars, Prof, Yusuf, Salim, Prof, Connolly, Stuart J, Prof

“…Summary Background Atrial fibrillation is an important cause of morbidity and mortality worldwide, but scant data are available for long-term outcomes in…”
Get full text

Effects of dabigatran according to age in atrial fibrillation by Lauw, Mandy N, Eikelboom, John W, Coppens, Michiel, Wallentin, Lars, Yusuf, Salim, Ezekowitz, Michael, Oldgren, Jonas, Nakamya, Juliet, Wang, Jia, Connolly, Stuart J

“…The prevalence of atrial fibrillation (AF) and the risk of stroke and bleeding vary according to age. To estimate effects of dabigatran, compared with…”
Get more information

Estimated stroke risk, yield, and number needed to screen for atrial fibrillation detected through single time screening: a multicountry patient-level meta-analysis of 141,220 screened individuals by Lowres, Nicole, Olivier, Jake, Chao, Tze-Fan, Chen, Shih-Ann, Chen, Yi, Diederichsen, Axel, Fitzmaurice, David A, Gomez-Doblas, Juan Jose, Harbison, Joseph, Healey, Jeff S, Hobbs, F D Richard, Kaasenbrood, Femke, Keen, William, Lee, Vivian W, Lindholt, Jes S, Lip, Gregory Y H, Mairesse, Georges H, Mant, Jonathan, Martin, Julie W, Martín-Rioboó, Enrique, McManus, David D, Muñiz, Javier, Münzel, Thomas, Nakamya, Juliet, Neubeck, Lis, Orchard, Jessica J, Pérula de Torres, Luis Ángel, Proietti, Marco, Quinn, F Russell, Roalfe, Andrea K, Sandhu, Roopinder K, Schnabel, Renate B, Smyth, Breda, Soni, Apurv, Tieleman, Robert, Wang, Jiguang, Wild, Philipp S, Yan, Bryan P, Freedman, Ben

“…The precise age distribution and calculated stroke risk of screen-detected atrial fibrillation (AF) is not known. Therefore, it is not possible to determine…”
Get full text

Predictors of Intracranial Hemorrhage Volume Expansion in Patients Receiving Factor Xa Inhibitors in ANNEXA‐4: Time and Severity Matter Most by Concha, Mauricio, Xu, Lizhen, Horn, MacKenzie, Ohara, Tomoyuki, Nakamya, Juliet, Beyer‐Westendorf, Jan, Shoamanesh, Ashkan, Cohen, Alexander, Ladenvall, Per, Connolly, Stuart J., Demchuk, Andrew M.

“…BackgroundAndexanet alfa, a specific reversal agent for factor Xa inhibitors, resulted in effective hemostasis in 79% of patients with intracranial bleeding in…”
Get full text

LVS-HARMED Risk Score for Incident Heart Failure in Patients With Atrial Fibrillation Who Present to the Emergency Department: Data from a World-Wide Registry by Johnson, Linda S B, Oldgren, Jonas, Barrett, Tyler W, McNaughton, Candace D, Wong, Jorge A, McIntyre, William F, Freeman, Clifford L, Murphy, Laura, Engström, Gunnar, Ezekowitz, Michael, Connolly, Stuart J, Xu, Lizhen, Nakamya, Juliet, Conen, David, Bangdiwala, Shrikant I, Yusuf, Salim, Healey, Jeff S

“…Background Heart failure (HF) is a common complication to atrial fibrillation (AF), leading to rehospitalization and death. Early identification of patients…”
Get full text

Diagnostic accuracy and yield of screening tests for atrial fibrillation in the family practice setting: a multicentre cohort study by Quinn, F Russell, Gladstone, David J, Ivers, Noah M, Sandhu, Roopinder K, Dolovich, Lisa, Ling, Andrea, Nakamya, Juliet, Ramasundarahettige, Chinthanie, Frydrych, Paul A, Henein, Sam, Ng, Ken, Congdon, Valerie, Birtwhistle, Richard V, Ward, Richard, Healey, Jeffrey S

“…Detection of undiagnosed or undertreated ("actionable") atrial fibrillation could increase the use of appropriate oral anticoagulant therapy and reduce the…”
Get full text

Concomitant Use of Antiplatelet Therapy with Dabigatran or Warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Trial by DANS, Antonio L, CONNOLLY, Stuart J, YUSUF, Salim, WALLENTIN, Lars, YANG, Sean, NAKAMYA, Juliet, BRUECKMANN, Martina, EZEKOWITZ, Michael, OLDGREN, Jonas, EIKELBOOM, John W, REILLY, Paul A

“…The Randomized Evaluation of Long-term Anticoagulation Therapy (RE-LY) trial showed that dabigatran etexilate 150 mg BID was superior and dabigatran etexilate…”
Get full text

Variations in Cause and Management of Atrial Fibrillation in a Prospective Registry of 15 400 Emergency Department Patients in 46 Countries: The RE-LY Atrial Fibrillation Registry by Oldgren, Jonas, Healey, Jeff S, Ezekowitz, Michael, Commerford, Patrick, Avezum, Alvaro, Pais, Prem, Zhu, Jun, Jansky, Petr, Sigamani, Alben, Morillo, Carlos A, Liu, Lisheng, Damasceno, Albertino, Grinvalds, Alex, Nakamya, Juliet, Reilly, Paul A, Keltai, Katalin, Van Gelder, Isabelle C, Yusufali, Afzal Hussein, Watanabe, Eiichi, Wallentin, Lars, Connolly, Stuart J, Yusuf, Salim

“…BACKGROUND—Atrial fibrillation (AF) is the most common sustained arrhythmia; however, little is known about patients in a primary care setting from high-,…”
Get full text

Hemostatic Efficacy and Anti-FXa (Factor Xa) Reversal With Andexanet Alfa in Intracranial Hemorrhage: ANNEXA-4 Substudy by Demchuk, Andrew M., Yue, Patrick, Zotova, Elena, Nakamya, Juliet, Xu, Lizhen, Milling, Truman J., Ohara, Tomoyuki, Goldstein, Joshua N., Middeldorp, Saskia, Verhamme, Peter, Lopez-Sendon, Jose Luis, Conley, Pamela B., Curnutte, John T., Eikelboom, John W., Crowther, Mark, Connolly, Stuart J.

“…Andexanet alfa is a recombinant modified human FXa (factor Xa) developed to reverse FXa inhibition from anticoagulants. Hemostatic efficacy and reversal of…”
Get full text

Abstract WP126: Predictors Of Intracranial Hemorrhage Volume Expansion In Patients Receiving Factor Xa Inhibitors In The Annexa-4 Trial by Concha, Mauricio, Hu, Lizhen, Horn, MacKenzie, Ohara, Tomoyuki, Nakamya, Juliet, Beyer, Jan, Shoamanesh, Askan, Cohen, Alexander T, Ladenvall, Per, Connolly, Stuart J, Demchuk, Andrew M

“…IntroductionAndexanet, a specific reversal agent for FXa inhibitors, showed an effective hemostasis in 82% of patients with major bleeding in the ANNEXA-4…”
Get full text

579 The Efficacy and Safety of Andexanet Alfa in Patients With Acute Gastrointestinal Bleeding While Taking Factor Xa Inhibitors: An ANNEXA-4 Sub-Analysis by Siegal, Deborah, Beyer-Westendorf, Jan, Yue, Patrick, Souza, Sonia, Nakamya, Juliet, Connolly, Stuart J., Crowther, Mark

Get full text

Hemostatic Efficacy and Anti-FXa (Factor Xa) Reversal With Andexanet Alfa in Intracranial Hemorrhage: ANNEXA-4 Substudy by Demchuk, Andrew M., Yue, Patrick, Zotova, Elena, Nakamya, Juliet, Xu, Lizhen, Milling, Truman J., Ohara, Tomoyuki, Goldstein, Joshua N., Middeldorp, Saskia, Verhamme, Peter, Lopez-Sendon, Jose Luis, Conley, Pamela B., Curnutte, John T., Eikelboom, John W., Crowther, Mark, Connolly, Stuart J.

Get full text

Left Atrial Appendage Occlusion during Cardiac Surgery to Prevent Stroke by Whitlock, Richard P., Belley-Cote, Emilie P., Paparella, Domenico, Healey, Jeff S., Brady, Katheryn, Sharma, Mukul, Reents, Wilko, Budera, Petr, Baddour, Andony J., Fila, Petr, Devereaux, P.J., Bogachev-Prokophiev, Alexander, Boening, Andreas, Teoh, Kevin H.T., Tagarakis, Georgios I., Slaughter, Mark S., Royse, Alistair G., McGuinness, Shay, Alings, Marco, Punjabi, Prakash P., Mazer, C. David, Folkeringa, Richard J., Colli, Andrea, Avezum, Álvaro, Nakamya, Juliet, Balasubramanian, Kumar, Vincent, Jessica, Voisine, Pierre, Lamy, Andre, Yusuf, Salim, Connolly, Stuart J.

Get full text

Is Screening for Atrial Fibrillation in Canadian Family Practices Cost-Effective in Patients 65 Years and Older? by Tarride, Jean-Eric, Quinn, F. Russell, Blackhouse, Gord, Sandhu, Roopinder K., Burke, Natasha, Gladstone, David J., Ivers, Noah M., Dolovich, Lisa, Thornton, Andrea, Nakamya, Juliet, Ramasundarahettige, Chinthanie, Frydrych, Paul A., Henein, Sam, Ng, Ken, Congdon, Valerie, Birtwhistle, Richard V., Ward, Richard, Healey, Jeffrey S.

“…We present an economic evaluation of a recently completed cohort study in which 2054 seniors were screened for atrial fibrillation (AF) in 22 Canadian family…”
Get full text

Andexanet Alfa for the Management of Acute Major Bleeding Associated with FXa Inhibitors (P5.059) by Connolly, Stuart J., Milling, Truman J., Eikelboom, John W., Gibson, C. Michael, Curnutte, John T., Gold, Alex, Lu, Genmin, Conley, Pamela B., Verhamme, Peter, Schmidt, Jeannot, Middeldorp, Saskia, Cohen, Alexander T., Beyer-Westendorf, Jan, Albaladejo, Pierre, Lopez-Sendon, Jose, Goodman, Shelly, Leeds, Janet M., Siegal, Deborah M., Zotova, Elena, Nakamya, Juliet, Lim, W. Ting, Crowther, Mark

“…Abstract only…”
Get full text